These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 8747732)
1. Management of candida septicaemia in a regional burn unit. Still JM; Belcher K; Law EJ Burns; 1995 Dec; 21(8):594-6. PubMed ID: 8747732 [TBL] [Abstract][Full Text] [Related]
2. Candida parapsilosis sepsis in patients with burns: report of six cases. Green D; Still JM; Law EJ J Burn Care Rehabil; 1994; 15(3):240-3. PubMed ID: 8056814 [TBL] [Abstract][Full Text] [Related]
3. [Retrospective evaluation of the cases with Candida famata fungemia in a burn unit]. Turunç T; Demiroğlu YZ; Alişkan H; Colakoğlu S; Arslan H Mikrobiyol Bul; 2009 Jan; 43(1):71-6. PubMed ID: 19334382 [TBL] [Abstract][Full Text] [Related]
4. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Nolla-Salas J; Sitges-Serra A; León-Gil C; Martínez-González J; León-Regidor MA; Ibáñez-Lucía P; Torres-Rodríguez JM Intensive Care Med; 1997 Jan; 23(1):23-30. PubMed ID: 9037636 [TBL] [Abstract][Full Text] [Related]
5. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. Minari A; Hachem R; Raad I Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906 [TBL] [Abstract][Full Text] [Related]
6. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients]. Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669 [TBL] [Abstract][Full Text] [Related]
7. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Benjamin DK; Ross K; McKinney RE; Benjamin DK; Auten R; Fisher RG Pediatrics; 2000 Oct; 106(4):712-8. PubMed ID: 11015513 [TBL] [Abstract][Full Text] [Related]
8. A ten-year review of Candida sepsis and mortality in burn patients. Prasad JK; Feller I; Thomson PD Surgery; 1987 Feb; 101(2):213-6. PubMed ID: 3810491 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981 [TBL] [Abstract][Full Text] [Related]
10. Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis. Kontoyiannis DP; Bodey GP; Mantzoros CS Mycoses; 2001; 44(5):125-35. PubMed ID: 11486448 [TBL] [Abstract][Full Text] [Related]
11. Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. Huttova M; Hartmanova I; Kralinsky K; Filka J; Uher J; Kurak J; Krizan S; Krcmery V Pediatr Infect Dis J; 1998 Nov; 17(11):1012-5. PubMed ID: 9849984 [TBL] [Abstract][Full Text] [Related]
12. [Epidemiology of fungemia in a university hospital; therapeutic incidence]. Pavese P; Brion JP; Lebeau B; Grillot R; Ambroise-Thomas P Pathol Biol (Paris); 1999 May; 47(5):579-83. PubMed ID: 10418046 [TBL] [Abstract][Full Text] [Related]
13. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Anaissie EJ; Vartivarian SE; Abi-Said D; Uzun O; Pinczowski H; Kontoyiannis DP; Khoury P; Papadakis K; Gardner A; Raad II; Gilbreath J; Bodey GP Am J Med; 1996 Aug; 101(2):170-6. PubMed ID: 8757357 [TBL] [Abstract][Full Text] [Related]
14. Candidemia and invasive candidiasis: a review of the literature for the burns surgeon. Ha JF; Italiano CM; Heath CH; Shih S; Rea S; Wood FM Burns; 2011 Mar; 37(2):181-95. PubMed ID: 20395056 [TBL] [Abstract][Full Text] [Related]
15. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients. Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P Infection; 1996; 24(6):426-32. PubMed ID: 9007589 [TBL] [Abstract][Full Text] [Related]
17. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
18. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Nguyen MH; Peacock JE; Morris AJ; Tanner DC; Nguyen ML; Snydman DR; Wagener MM; Rinaldi MG; Yu VL Am J Med; 1996 Jun; 100(6):617-23. PubMed ID: 8678081 [TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibilities of Candida species isolated from urine culture. Toka Özer T; Durmaz S; Yula E J Infect Chemother; 2016 Sep; 22(9):629-32. PubMed ID: 27452427 [TBL] [Abstract][Full Text] [Related]
20. Hospital-acquired candidaemia: experience from a developing country. al Soub H; Estinoso W J Hosp Infect; 1997 Feb; 35(2):141-7. PubMed ID: 9049818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]